Gene expression profiling in peripheral blood mononuclear cells of patients with common variable immunodeficiency: modulation of adaptive immune response following intravenous immunoglobulin therapy.

<h4>Background</h4>Regular intravenous immunoglobulin treatment is used to replace antibody deficiency in primary immunodeficiency diseases; however the therapeutic effect seems to be related not only to antibody replacement but also to an active role in the modulation of the immune resp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marzia Dolcino, Giuseppe Patuzzo, Alessandro Barbieri, Elisa Tinazzi, Monica Rizzi, Ruggero Beri, Giuseppe Argentino, Andrea Ottria, Claudio Lunardi, Antonio Puccetti
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/1d9ef2abdd8342708dac08ddc6ba3042
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1d9ef2abdd8342708dac08ddc6ba3042
record_format dspace
spelling oai:doaj.org-article:1d9ef2abdd8342708dac08ddc6ba30422021-11-18T08:19:05ZGene expression profiling in peripheral blood mononuclear cells of patients with common variable immunodeficiency: modulation of adaptive immune response following intravenous immunoglobulin therapy.1932-620310.1371/journal.pone.0097571https://doaj.org/article/1d9ef2abdd8342708dac08ddc6ba30422014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24831519/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Regular intravenous immunoglobulin treatment is used to replace antibody deficiency in primary immunodeficiency diseases; however the therapeutic effect seems to be related not only to antibody replacement but also to an active role in the modulation of the immune response. Common variable immunodeficiency is the most frequent primary immunodeficiency seen in clinical practice.<h4>Methods</h4>We have studied the effect of intravenous immunoglobulin replacement in patients with common variable immunodeficiency by evaluating the gene-expression profiles from Affimetrix HG-U133A. Some of the gene array results were validated by real time RT-PCR and by the measurement of circulating cytokines and chemokines by ELISA. Moreover we performed FACS analysis of blood mononuclear cells from the patients enrolled in the study.<h4>Results</h4>A series of genes involved in innate and acquired immune responses were markedly up- or down-modulated before therapy. Such genes included CD14, CD36, LEPR, IRF-5, RGS-1, CD38, TNFRSF25, IL-4, CXCR4, CCR3, IL-8. Most of these modulated genes showed an expression similar to that of normal controls after immunoglobulin replacement. Real time RT-PCR of selected genes and serum levels of IL-4, CXCR4 before and after therapy changed accordingly to gene array results. Interestingly, serum levels of IL-8 remained unchanged, as the corresponding gene, before and after treatment. FACS analysis showed a marked decrease of CD8+T cells and an increase of CD4+T cells following treatment. Moreover we observed a marked increase of CD23⁻CD27⁻IgM⁻IgG⁻ B cells (centrocytes).<h4>Conclusions</h4>Our results are in accordance with previous reports and provide further support to the hypothesis that the benefits of intravenous immunoglobulin therapy are not only related to antibody replacement but also to its ability to modulate the immune response in common variable immunodeficiency.Marzia DolcinoGiuseppe PatuzzoAlessandro BarbieriElisa TinazziMonica RizziRuggero BeriGiuseppe ArgentinoAndrea OttriaClaudio LunardiAntonio PuccettiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 5, p e97571 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Marzia Dolcino
Giuseppe Patuzzo
Alessandro Barbieri
Elisa Tinazzi
Monica Rizzi
Ruggero Beri
Giuseppe Argentino
Andrea Ottria
Claudio Lunardi
Antonio Puccetti
Gene expression profiling in peripheral blood mononuclear cells of patients with common variable immunodeficiency: modulation of adaptive immune response following intravenous immunoglobulin therapy.
description <h4>Background</h4>Regular intravenous immunoglobulin treatment is used to replace antibody deficiency in primary immunodeficiency diseases; however the therapeutic effect seems to be related not only to antibody replacement but also to an active role in the modulation of the immune response. Common variable immunodeficiency is the most frequent primary immunodeficiency seen in clinical practice.<h4>Methods</h4>We have studied the effect of intravenous immunoglobulin replacement in patients with common variable immunodeficiency by evaluating the gene-expression profiles from Affimetrix HG-U133A. Some of the gene array results were validated by real time RT-PCR and by the measurement of circulating cytokines and chemokines by ELISA. Moreover we performed FACS analysis of blood mononuclear cells from the patients enrolled in the study.<h4>Results</h4>A series of genes involved in innate and acquired immune responses were markedly up- or down-modulated before therapy. Such genes included CD14, CD36, LEPR, IRF-5, RGS-1, CD38, TNFRSF25, IL-4, CXCR4, CCR3, IL-8. Most of these modulated genes showed an expression similar to that of normal controls after immunoglobulin replacement. Real time RT-PCR of selected genes and serum levels of IL-4, CXCR4 before and after therapy changed accordingly to gene array results. Interestingly, serum levels of IL-8 remained unchanged, as the corresponding gene, before and after treatment. FACS analysis showed a marked decrease of CD8+T cells and an increase of CD4+T cells following treatment. Moreover we observed a marked increase of CD23⁻CD27⁻IgM⁻IgG⁻ B cells (centrocytes).<h4>Conclusions</h4>Our results are in accordance with previous reports and provide further support to the hypothesis that the benefits of intravenous immunoglobulin therapy are not only related to antibody replacement but also to its ability to modulate the immune response in common variable immunodeficiency.
format article
author Marzia Dolcino
Giuseppe Patuzzo
Alessandro Barbieri
Elisa Tinazzi
Monica Rizzi
Ruggero Beri
Giuseppe Argentino
Andrea Ottria
Claudio Lunardi
Antonio Puccetti
author_facet Marzia Dolcino
Giuseppe Patuzzo
Alessandro Barbieri
Elisa Tinazzi
Monica Rizzi
Ruggero Beri
Giuseppe Argentino
Andrea Ottria
Claudio Lunardi
Antonio Puccetti
author_sort Marzia Dolcino
title Gene expression profiling in peripheral blood mononuclear cells of patients with common variable immunodeficiency: modulation of adaptive immune response following intravenous immunoglobulin therapy.
title_short Gene expression profiling in peripheral blood mononuclear cells of patients with common variable immunodeficiency: modulation of adaptive immune response following intravenous immunoglobulin therapy.
title_full Gene expression profiling in peripheral blood mononuclear cells of patients with common variable immunodeficiency: modulation of adaptive immune response following intravenous immunoglobulin therapy.
title_fullStr Gene expression profiling in peripheral blood mononuclear cells of patients with common variable immunodeficiency: modulation of adaptive immune response following intravenous immunoglobulin therapy.
title_full_unstemmed Gene expression profiling in peripheral blood mononuclear cells of patients with common variable immunodeficiency: modulation of adaptive immune response following intravenous immunoglobulin therapy.
title_sort gene expression profiling in peripheral blood mononuclear cells of patients with common variable immunodeficiency: modulation of adaptive immune response following intravenous immunoglobulin therapy.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/1d9ef2abdd8342708dac08ddc6ba3042
work_keys_str_mv AT marziadolcino geneexpressionprofilinginperipheralbloodmononuclearcellsofpatientswithcommonvariableimmunodeficiencymodulationofadaptiveimmuneresponsefollowingintravenousimmunoglobulintherapy
AT giuseppepatuzzo geneexpressionprofilinginperipheralbloodmononuclearcellsofpatientswithcommonvariableimmunodeficiencymodulationofadaptiveimmuneresponsefollowingintravenousimmunoglobulintherapy
AT alessandrobarbieri geneexpressionprofilinginperipheralbloodmononuclearcellsofpatientswithcommonvariableimmunodeficiencymodulationofadaptiveimmuneresponsefollowingintravenousimmunoglobulintherapy
AT elisatinazzi geneexpressionprofilinginperipheralbloodmononuclearcellsofpatientswithcommonvariableimmunodeficiencymodulationofadaptiveimmuneresponsefollowingintravenousimmunoglobulintherapy
AT monicarizzi geneexpressionprofilinginperipheralbloodmononuclearcellsofpatientswithcommonvariableimmunodeficiencymodulationofadaptiveimmuneresponsefollowingintravenousimmunoglobulintherapy
AT ruggeroberi geneexpressionprofilinginperipheralbloodmononuclearcellsofpatientswithcommonvariableimmunodeficiencymodulationofadaptiveimmuneresponsefollowingintravenousimmunoglobulintherapy
AT giuseppeargentino geneexpressionprofilinginperipheralbloodmononuclearcellsofpatientswithcommonvariableimmunodeficiencymodulationofadaptiveimmuneresponsefollowingintravenousimmunoglobulintherapy
AT andreaottria geneexpressionprofilinginperipheralbloodmononuclearcellsofpatientswithcommonvariableimmunodeficiencymodulationofadaptiveimmuneresponsefollowingintravenousimmunoglobulintherapy
AT claudiolunardi geneexpressionprofilinginperipheralbloodmononuclearcellsofpatientswithcommonvariableimmunodeficiencymodulationofadaptiveimmuneresponsefollowingintravenousimmunoglobulintherapy
AT antoniopuccetti geneexpressionprofilinginperipheralbloodmononuclearcellsofpatientswithcommonvariableimmunodeficiencymodulationofadaptiveimmuneresponsefollowingintravenousimmunoglobulintherapy
_version_ 1718421910463709184